Konstantinopoulos, Panagiotis A. http://orcid.org/0000-0002-1032-1479
da Costa, Alexandre André B. A. http://orcid.org/0000-0002-1631-0105
Gulhan, Doga
Lee, Elizabeth K. http://orcid.org/0000-0001-7533-7853
Cheng, Su-Chun
Hendrickson, Andrea E. Wahner
Kochupurakkal, Bose
Kolin, David L. http://orcid.org/0000-0002-7631-6525
Kohn, Elise C.
Liu, Joyce F.
Stover, Elizabeth H. http://orcid.org/0000-0002-6578-3216
Curtis, Jennifer
Tayob, Nabihah
Polak, Madeline http://orcid.org/0000-0002-1331-3845
Chowdhury, Dipanjan http://orcid.org/0000-0001-5645-3752
Matulonis, Ursula A.
Färkkilä, Anniina http://orcid.org/0000-0002-3558-6617
D’Andrea, Alan D. http://orcid.org/0000-0001-6168-6294
Shapiro, Geoffrey I. http://orcid.org/0000-0002-3331-4095
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (UM1 CA186709, 1P50CA240243)
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Article History
Received: 9 February 2021
Accepted: 1 September 2021
First Online: 22 September 2021
Competing interests
: A.D.D. is a consultant/advisory board member for Merck-EMD-Serono. G.I.S. has received research funding from Merck KGaA/EMD-Serono and has served on advisory boards for Merck KGaA/EMD-Serono DNA repair inhibitors. The remaining authors declare no competing interests.